Posted in | News | Nanobusiness

Companies to Jointly Present Nanotechnology Seminar

Brinks Hofer Gilson + Lione, one of the largest intellectual property law firms in the U.S., and the NanoBusiness Alliance will jointly present a nanotechnology seminar at Brinks' offices in Chicago on Wednesday, December 9, 2009, from 2 to 5:30pm.

The Illinois MCLE-accredited seminar will feature presentations from leading experts in academia, business and intellectual property who will address cutting-edge topics in nanotechnology.

Guest speakers include:

Sean Murdock, executive director, NanoBusiness Alliance, who will discuss developments in nanotechnology;
Mohan Rao, Ph.D., managing director, LECG, who will cover valuation of early-stage technologies; and
Vinayak P. Dravid, Ph.D., director, Northwestern University Atomic and Nanoscale Characterization Experimental Center, who will address investor perceptions and misperceptions.
Speakers from Brinks include attorneys Laura Beth Miller, chair of the firm’s International Trade Commission Group, James Naughton, chair of the Green Technology Group, and Christopher Wight, counsel at Brinks specializing in patents and complex technology transfer.

After the seminar, attendees are invited to join executives, academics, entrepreneurs, investors, attorneys and other professionals at the NanoBusiness Alliance’s annual holiday party, from 5:30pm to 8pm.

Both events take place at the offices of Brinks Hofer Gilson & Lione, NBC Tower, Suite 3600, 455 North Cityfront Plaza Drive, Chicago.

The events are free; however, registration is requested by December 7, 2009.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.